연구성과로 돌아가기

2025 연구성과별 연구자 정보 (507 / 1187)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Lee, Gyeong-Won Lee, GW 4 Gyeongsang Natl Univ, Coll Med, Gyeongsang Natl Univ Hosp,Inst Hlth Sci, Div Hematol & Oncol,Dept Internal Med, Jinju, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Sohn, Sang Kyun Sohn, SK 5 Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Shin, Ho-Jin Shin, HJ 6 Pusan Natl Univ Hosp, Dept Hematol Oncol, Busan, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Bae, Sung Hwa Bae, SH 7 Daegu Catholic Univ, Dept Internal Med, Div Hematol Oncol, Sch Med,Daegu Catholic Univ Hosp, Daegu, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Choi, Chul Won Choi, CW 8 Korea Univ, Guro Hosp, Div Oncol & Hematol, Dept Internal Med, Seoul, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Choi, Eun-Ji Choi, EJ 9 Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Cheong, June-Won Cheong, JW 10 Yonsei Univ, Coll Med, Severance Hosp,Dept Internal Med, Div Hematol, Seoul, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Bang, Soo-Mee Bang, SM 11 Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Park, Joon Seong Park, JS 12 Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Oh, Suk Joong Oh, SJ 13 Hanyang Univ, Dept Oncol, Asan Med Ctr, Seoul 138736, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Park, Yong Park, Y 14 Korea Univ, Coll Med, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Park, Young Hoon Park, YH 15 Ewha Womans Univ, Mokdong Hosp, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea lee86@catholic.ac.kr;
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study Lee, Sung-Eun Lee, SE 16 교신저자 Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hematol, 222 Banpodae Ro, Seoul 06591, South Korea GPW-6306-2022 Lee, SangHun lee86@catholic.ac.kr;
Hemoglobin Trajectory in Patients With Interstitial Lung Disease Choi, W. -I. Choi, WI 1 Hanyang Univ, Myongji Hosp, Goyang Si, South Korea
Hemoglobin Trajectory in Patients With Interstitial Lung Disease Jang, H. Jang, H 2 Inha Univ, Inha Univ Hosp, Coll Med, Incheon, South Korea
페이지 이동: